Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. | Sci Rep | 2023 | 37316699 | PubTator, text mining | PubMed |
| Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells. | Sci Rep | 2023 | 37302991 | PubTator, text mining | PubMed |
| A Blinded Investigation: Accentuated NK Lymphocyte CD335 (NKp46) Expression Predicts Pregnancy Failures. | Diagnostics (Basel) | 2023 | 37296696 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the role of USP5 in human cancers. | Sci Rep | 2023 | 37268697 | PubTator, text mining | PubMed |
Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence. | BMC Cancer | 2023 | 37254046 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer. | FEBS Open Bio | 2023 | 37243901 | PubTator, text mining | PubMed |
| NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | 37228595 | PubTator, text mining | PubMed |
| Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies. | Front Immunol | 2023 | 37207215 | PubTator, text mining | PubMed |
| Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real-world experience of a referral center. | EJHaem | 2023 | 37206286 | PubTator, text mining | PubMed |
| Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge. | PLoS Pathog | 2023 | 37195999 | PubTator, text mining | PubMed |
| Purification of primary human placental leukocytes to study maternal-fetal interactions. | STAR Protoc | 2023 | 37182206 | PubTator, text mining | PubMed |
| Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. | Int J Mol Sci | 2023 | 37175450 | PubTator, text mining | PubMed |
| Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. | Sci Rep | 2023 | 37169953 | PubTator, text mining | PubMed |
| Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. | Genome Res | 2023 | 37169596 | PubTator, text mining | PubMed |
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| Interleukin-15 deficient rats have reduced osteopontin at the maternal-fetal interface. | Front Cell Dev Biol | 2023 | 37152295 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics. | Front Immunol | 2023 | 37138889 | PubTator, text mining | PubMed |
| Human leukocyte antigen and tumor immunotherapy (Review). | Int J Oncol | 2023 | 37114561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=9